Literature DB >> 3067055

Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli.

A E Franke, G C Andrews, N P Stimler-Gerard, C J Gerard, H J Showell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067055     DOI: 10.1016/0076-6879(88)62107-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.

Authors:  E R Pettipher; E D Salter; R Breslow; L Raycroft; H J Showell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

2.  Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.

Authors:  D F Carney; T E Hugli
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

3.  The pharmacophore of the human C5a anaphylatoxin.

Authors:  M J Toth; L Huwyler; W C Boyar; A F Braunwalder; D Yarwood; J Hadala; W O Haston; M A Sills; B Seligmann; N Galakatos
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

4.  A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.

Authors:  W Bautsch; T Kretzschmar; T Stühmer; A Kola; M Emde; J Köhl; A Klos; D Bitter-Suermann
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

5.  Expression and subcellular targeting of human complement factor C5a in Nicotiana species.

Authors:  Henrik Nausch; Heike Mikschofsky; Heike Mischofsky; Roswitha Koslowski; Udo Meyer; Inge Broer; Jana Huckauf
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

6.  Comparative analysis of different biofactories for the production of a major diabetes autoantigen.

Authors:  Linda Avesani; Matilde Merlin; Elisa Gecchele; Stefano Capaldi; Annalisa Brozzetti; Alberto Falorni; Mario Pezzotti
Journal:  Transgenic Res       Date:  2013-10-20       Impact factor: 2.788

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.